Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ZALUPSKI M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 17 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zonder, JA; Shields, AF; Zalupski, M; Chaplen, R; Heilbrun, LK; Arlauskas, P; Philip, PA
      A phase II trial of bryostatin 1 in the treatment of metastatic colorectalcancer

      CLINICAL CANCER RESEARCH
    2. Prakash, S; Foster, BJ; Meyer, M; Wozniak, A; Heilbrun, LK; Flaherty, L; Zalupski, M; Radulovic, L; Valdivieso, M; LoRusso, PM
      Chronic oral administration of CI-994: A phase 1 study

      INVESTIGATIONAL NEW DRUGS
    3. Philip, PA; Ibrahim, D; Zalupski, M; Arlauskas, P; Shields, A
      Gemcitabine and UFT plus oral calcium folinate: Phase I study

      ONCOLOGY-NEW YORK
    4. LORUSSO PM; FOSTER B; WOZNIAK A; FLAHERTY L; SHIELDS A; ZALUPSKI M; KOCAREK T; GRIESHABER CK; PARCHMENT RE
      PHASE-I CLINICAL-TRIAL OF KRN5500

      Annals of oncology
    5. LUCAS D; RABAH R; RYAN J; NADIM Y; GROSS M; ZALUPSKI M; RAVINDRANATH Y
      PRIMARY RHABDOMYOSARCOMA (RMS), LEIOMYOSARCOMA (LMS), LIPOSARCOMA (LPS), AND ALVEOLAR SOFT PARTS SARCOMA (ASPS) OF BONE - 4 CASE-REPORTS

      Modern pathology
    6. DAVILA J; SARKAR F; DU W; ARLAUSKAS P; SHIELDS A; ZALUPSKI M; VAITKEVICIUS V; CRISSMAN J; ADSAY V
      MULTIDRUG-RESISTANCE PROTEINS (GLUTATHIONE-S TRANSFERASE-ALPHA AND TRANSFERASE-PI AND P-GLYCOPROTEINS) AND RESPONSE TO CHEMOTHERAPY IN PANCREAS CANCER

      Modern pathology
    7. LUCAS D; RABAH R; RYAN J; NADIM Y; GROSS M; ZALUPSKI M; RAVINDRANATH Y
      PRIMARY RHABDOMYOSARCOMA (RMS), LEIOMYOSARCOMA (LMS), LIPOSARCOMA (LPS), AND ALVEOLAR SOFT PARTS SARCOMA (ASPS) OF BONE - 4 CASE-REPORTS

      Laboratory investigation
    8. BENJOSEF E; CHUBA P; FONTANESI J; ZALUPSKI M; RYAN JR; FILIPZACK L; PORTER AT
      RADIOTHERAPY AS A SURGICAL ADJUNCT IN SOFT-TISSUE SARCOMA OF THE RETROPERITONEUM, PELVIS, AND TRUNK

      International journal of radiation oncology, biology, physics
    9. VARTERASIAN M; ZALUPSKI M; KARANES C
      THE HETEROGENEITY OF LEUKEMIA OCCURRING AFTER TREATMENT FOR SARCOMA

      American journal of clinical oncology
    10. HICKS LG; BALCERZAK SP; ZALUPSKI M
      GM-CSF DID NOT ALLOW DOXORUBICIN DOSE-ESCALATION IN THE MAID REGIMEN - A PHASE-I TRIAL - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Cancer investigation
    11. BUDD GT; SAMUELS B; GOCKERMAN J; BAKER L; MARGOLIN K; ZALUPSKI M; FELSER J; JOHNSON B; ISAACS R; BUKOWSKI RM
      RANDOMIZED TRIAL OF MAID (MESNA, ADRIAMYCIN, IFOSFAMIDE, DECARBAZINE)CHEMOTHERAPY WITH G-CSF ALONE OR WITH G-CSF PLUS VARYING DOSES OF INTERLEUKIN-6 (IL-6)

      Blood
    12. REDMAN BG; CHOU TH; ZALUPSKI M; UBERTI J; FLAHERTY L; DAN M; SENSENBRENNER L
      PHASE-I TRIAL OF SEQUENTIAL CYCLOPHOSPHAMIDE, CYCLOSPORINE-A, AND INTERFERON-ALPHA IN PATIENTS WITH CANCER - ATTEMPT TO INDUCE AUTOLOGOUS GRAFT-VERSUS-HOST REACTION TO ELICIT AN ANTITUMOR RESPONSE

      Journal of immunotherapy with emphasis on tumor immunology
    13. BENJOSEF E; FONTANESI J; ZALUPSKI M; BRUSSEAU TE; RYAN JR
      CONSERVATIVE RESECTION WITHOUT RADIOTHERAPY FOR LOCAL-CONTROL OF EWINGS-SARCOMA

      European journal of cancer
    14. FOSTER BJ; LORUSSO PM; POPLIN E; ZALUPSKI M; VALDIVIESO M; WOZNIAK A; FLAHERTY L; KASUNIC DA; EARHART RH; BAKER LH
      PHASE-I TRIAL OF ADOZELESIN USING THE TREATMENT SCHEDULE OF DAILY X 5EVERY 3 WEEKS

      Investigational new drugs
    15. ALTUNGOZ O; MELONI AM; PEIER A; ZALUPSKI M; SPANIER S; BROOKS JSJ; SANDBERG AA
      DELETION 6Q IN 3 CASES OF MIXED-TYPE LIPOSARCOMA IN ADDITION TO T(12-16)(Q13-P11) (VOL 79, PG 104, 1995)

      Cancer genetics and cytogenetics
    16. ALTUNGOZ O; MELONI AM; PEIER A; ZALUPSKI M; SPANIER S; BROOKS JSJ; SANDBERG AA
      DELETION-6Q IN 3 CASES OF MIXED-TYPE LIPOSARCOMA IN ADDITION TO T(12-16)(Q13-P11)

      Cancer genetics and cytogenetics
    17. MOMIN FA; ZALUPSKI M; HEILBRUN LK; FLAHERTY L; FYFE G; BAKER LH; REDMAN BG
      PHASE-II TRIAL OF RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR IN METASTATIC SOFT-TISSUE SARCOMA

      Journal of immunotherapy with emphasis on tumor immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 19:06:35